Endocyte, Inc. EBITDA Margin 2011-2018 | ECYT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Endocyte, Inc. (ECYT) over the last 10 years. The current EBITDA margin for Endocyte, Inc. as of September 30, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-09-30 | $0.00B | $-0.04B | inf% |
| 2018-06-30 | $0.00B | $-0.05B | inf% |
| 2018-03-31 | $0.00B | $-0.05B | inf% |
| 2017-12-31 | $0.00B | $-0.06B | inf% |
| 2017-09-30 | $0.00B | $-0.06B | inf% |
| 2017-06-30 | $0.00B | $-0.04B | inf% |
| 2017-03-31 | $0.00B | $-0.05B | inf% |
| 2016-12-31 | $0.00B | $-0.04B | inf% |
| 2016-09-30 | $0.00B | $-0.04B | inf% |
| 2016-06-30 | $0.00B | $-0.04B | inf% |
| 2016-03-31 | $0.00B | $-0.04B | inf% |
| 2015-12-31 | $0.00B | $-0.04B | inf% |
| 2015-09-30 | $0.00B | $-0.04B | inf% |
| 2015-06-30 | $0.00B | $-0.03B | -825.00% |
| 2015-03-31 | $0.05B | $-0.00B | 0.00% |
| 2014-12-31 | $0.07B | $0.01B | 10.00% |
| 2014-09-30 | $0.09B | $0.01B | 14.94% |
| 2014-06-30 | $0.10B | $0.02B | 15.00% |
| 2014-03-31 | $0.07B | $-0.02B | -23.88% |
| 2013-12-31 | $0.07B | $-0.02B | -26.15% |
| 2013-09-30 | $0.06B | $-0.02B | -25.81% |
| 2013-06-30 | $0.06B | $-0.01B | -24.56% |
| 2013-03-31 | $0.05B | $-0.01B | -20.41% |
